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Abstract
Background: Previous studies have reported a reduction in acute coronary events following smoke-free legislation.
Evidence is lacking on whether stroke is also reduced. The aim was to determine whether the incidence of stroke, overall
and by sub-type, fell following introduction of smoke-free legislation across Scotland on 26 March 2006.
Methods and Findings: A negative binomial regression model was used to determine whether the introduction of smoke-
free legislation resulted in a step and/or slope change in stroke incidence. The model was adjusted for age-group, sex,
socioeconomic deprivation quintile, urban/rural residence and month. Interaction tests were also performed. Routine
hospital administrative data and death certificates were used to identify all hospital admissions and pre-hospital deaths due
to stroke (ICD10 codes I61, I63 and I64) in Scotland between 2000 and 2010 inclusive. Prior to the legislation, rates of all
stroke, intracerebral haemorrhage and unspecified stroke were decreasing, whilst cerebral infarction was increasing at
0.97% per annum. Following the legislation, there was a dramatic fall in cerebral infarctions that persisted for around 20
months. No visible effect was observed for other types of stroke. The model confirmed an 8.90% (95% CI 4.85, 12.77,
p,0.001) stepwise reduction in cerebral infarction at the time the legislation was implemented, after adjustment for
potential confounders.
Conclusions: Following introduction of national, comprehensive smoke-free legislation there was a selective reduction in
cerebral infarction that was not apparent in other types of stroke.
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Introduction
In Scotland, the Smoking, Health and Social Care (Scotland)
Bill prohibited smoking in virtually all wholly and substantially
enclosed public places and workplaces from 26 March 2006,
including bars, restaurants, cafes and private members clubs. The
few exemptions included designated rooms in residential accom-
modation, adult care homes, hotels and psychiatric units. The law
is enforced by Environmental Health Officers. It became illegal
both to smoke and to permit smoking in smoke-free premises. Both
the individuals who flout the legislation and the managers of
premises in which they are permitted to do so face fixed penalties.
Refusal or failure to pay either may result in prosecution and an
increased fine. The primary aim of the legislation was to protect
non-smokers from the adverse health effects of exposure to
environmental tobacco smoke (ETS), but it was anticipated that
health benefits might also accrue from a reduction in tobacco
consumption and smoking prevalence in the general population.
No other new, national tobacco control measures were introduced
over the study period.
Smoking is one of the major risk factors for stroke [1]. Cerebral
blood flow is reduced in chronic smokers [2], due to an increase in
platelet adhesiveness [3], fibringogen levels [4], blood viscosity [4],
and vascular resistance [5]. Compared with non-smokers, active
smoking is associated with a 2–4 fold increased risk of stroke [6]. In
comparison with non-smokers protected from environmental
tobacco smoke, the risk is up to 6-fold [7]. Smoking is also
associated with poorer functional outcome among those who suffer
stroke [8]. The increased risk of stroke among smokers persists for
several years after smoking cessation [4], suggesting that in
addition to pro-thrombotic effects, cigarette smoke predisposes to
atherogenesis. Active smoking is associated with both ischaemic
and haemorrhagic stroke [6,9], but the relative risk may be higher
for ischaemic strokes, particularly those due to thromboembolic
infarction [10]. Active smoking is not associated with atrial
fibrillation [11] and, therefore, is not associated with ischaemic
stroke due to cardiac emboli [10].
ETS is a mixture of non-inhaled side-stream smoke from
burning cigarette tips and main-stream smoke exhaled by smokers.
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Many toxic gases and small, respirable particles are present in
higher concentrations in ETS than in the mainstream smoke
inhaled by smokers. Exposure to small amounts of ETS
significantly and rapidly increases platelet aggregation, thrombosis,
endothelial dysfunction, and inflammation [12–16], resulting in
levels of homocysteine, C-reactive protein, fibrinogen and oxidized
low density lipoprotein cholesterol of similar magnitude to those in
active smokers [17]. An association between ETS exposure and
risk of all strokes has now been demonstrated in case-control [7],
cross-sectional [18], and cohort studies [19,20]. A number of
studies have focused on ischaemic stroke [10,19,21,22]. In a case-
control study, You et al. demonstrated an association between a
spouse smoking and risk of ischaemic stroke among both active
smokers and non-smokers [21]. There is evidence of a dose
response in relation to the number of cigarettes smoked by a
spouse [10,18,21,22], the amount of time spent smoking [21], and
the number of years they have smoked [18]. In a cross-sectional
study, He et al. demonstrated a significant association between
ETS and both total and ischaemic stroke (OR 1.56, 95% CI 1.03–
2.35), but not haemorrhagic stroke (OR 1.10, 95% CI 0.52–2.34)
(22). In a case-control study of sub-arachnoid haemorrhage,
Anderson et al demonstrated a strong association with active
smoking but no association with exposure to ETS [23]. Most
studies have relied on self-reported ETS exposure. In the British
Regional Heart Study, ETS was measured via cotinine assay [24].
The investigators demonstrated a dose relationship between
cotinine level and risk of stroke but this did not reach statistical
significance.
Many studies have demonstrated a significant reduction in the
incidence of acute coronary events following introduction of
smoke-free legislation [25,26]. Smoking increases the risk of acute
coronary events through a prothrombotic effect. Therefore, we
hypothesised that smoke-free legislation may also have reduced the
risk of stroke overall, and thrombotic stroke specifically.
Methods
Data Sources and Exclusion Criteria
Scotland has a population of around 5.1 million. The Scottish
Morbidity Record (SMR01) collects information on all admissions
to acute hospitals in Scotland including admission date, urgency of
admission, age, sex and postcode of residence. It also collects the
principal and secondary disease codes using the International
Classification of Diseases (ICD). The General Register Office for
Scotland collates death certificate data on all deaths that occur in
Scotland including those that occur in the community, as well as
in-hospital. The death certificate data include date of death, age,
sex, postcode of residence and the primary underlying cause of
death, classified using ICD. The individual-level data from both
systems are linked by the Information and Statistics Division (ISD)
of National Health Services Scotland enabling recurrent events in
the same individual to be identified. We used these data to identify
all emergency admissions and pre-hospital deaths due to a
principal diagnosis of stroke that occurred in Scotland between
2000 and 2010 inclusive. We excluded from our analysis people
who had suffered a stroke during the previous ten years. Since this
was a secondary analysis of existing, anonymised data we did not
obtain individual participant consent. Permission to use both sets
of data was granted by the Privacy Advisory Committee of the
Information and Statistics Division.
Definitions
Cerebral infarction was defined as a principal diagnosis of
ICD10 I63, intracerebral haemorrhagic stroke as a principal
diagnosis of ICD10 I61, and unspecified stroke as a principal
diagnosis of ICD10 I64. Confirmed strokes included both cerebral
infarction and intra-cerebral haemorrhage and excluded unspec-
ified stroke, and all strokes included both confirmed and
unspecified stroke. Events included both pre-hospital deaths and
hospital admissions, irrespective of whether the patient was
discharged alive or died in-hospital. Postcodes of residence were
aggregated into datazones of residence (http://www.scotland.gov.
uk/Topics/Statistics/SIMD/Overview). There are 6,505 data-
zones in Scotland with a median population of 769. Information
on 38 indicators across 7 domains, namely: income, employment,
health, education, skills and training, housing, geographic access
and crime, are collected at the Census and used to attribute a
Scottish Index of Multiple Deprivation (SIMD) to each datazone.
The Scottish Indices of Multiple Deprivation are then aggregated
into population quintiles of deprivation ranging from 1 (most
affluent) to 5 (most deprived). Categorisation of postcode of
residence into urban and rural was based on the Scottish
Executive’s Classification system (http://www.scotland.gov.uk/
Resource/Doc/47251/0028898.pdf). Large urban areas and
other urban areas were both coded as urban and the remainder
were coded as rural.
Statistical Analyses
We determined the frequency of stroke events each month for
sub-groups defined by age (,60 and $60 years), sex, deprivation
quintile and urban/rural classification. Annual population counts
in each of these sub-groups, for each month, were estimated by
linear extrapolation of annual small area population estimates
from the General Registrar (Scotland) Office (http://www.gro-
scotland.gov.uk/statistics/theme/population/estimates/special-
area/sape/archive/index.html) for data zones obtained from the
Scottish 2001 Census to which were matched the urban-rural
indicator and datazone quintile of deprivation. Adjustments to the
population counts were made for leap years. Separate negative
binomial regression models were fitted for all strokes and sub-types
of stroke. The models allowed for an underlying trend in incidence
rates throughout the whole study period, and for a step change
and change in trend after implementation of the smoke-free
legislation. The models were adjusted for actual age group, sex,
deprivation quintile, urban/rural classification, and month and
year. We included an offset term to account for different
population sizes and the number of days in each month. The
negative binomial models were compared to Poisson equivalents
using the Akaike information criterion (AIC) and Bayesian
information criterion (BIC) statistics and these confirmed that
negative binomial regression was more appropriate than Poisson
regression for our data. There was no evidence of over-dispersion
within the models. The models were extended to include
interaction terms to test for differences in the post-legislation
change in incidence trend between sub-groups of the population
(after allowing for different pre-legislation trends); specifically age
group, sex, deprivation quintile and urban/rural classification.
Results
Over the eleven year period, between 2000 and 2010 inclusive,
there were 86,835 stroke events: 35,810 cerebral infarctions, 9,210
intra-cerebral haemorrhages, and 41,815 unspecified strokes.
Of those 86,835, complete data was available on 85,662
(98.6%): 35,308 cerebral infarctions, 9,050 intra-cerebral haem-
orrhages and 41,304 unspecified strokes. Table 1 shows the
breakdown by age, sex, residence and deprivation. On visual
inspection, all stroke, intracerebral haemorrhage and unspecified
Smoke-Free Legislation and Stroke
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stroke were decreasing in incidence prior to implementation of the
legislation (Figure 1 & Figure S1). In contrast, the incidence of
cerebral infarction was rising (Figure 1 & Figure S1). Following
implementation of the legislation there appeared to be a dramatic
fall in cerebral infarction incidence that persisted for around 20
months before partially reverting to pre-legislation levels (Figure 1
& Figure S1). Visual inspection of the graphs for the other types of
stroke suggested no obvious effect of the legislation (Figure 1 &
Figure S1).
In the statistical model, the incidence of cerebral infarction
increased at 0.97% per annum prior to the legislation, after
adjusting for changes in age, sex, deprivation quintile and urban/
rural residence, as well as month of event. At the time of
implementation there was a stepwise absolute reduction of 8.90%
(95% CI 4.85, 12.77, p,0.001) (Table 1). The stepwise reduction
in incidence reached statistical significance in most sub-groups of
the population (Table 1). None of the formal tests for interactions
between sub-groups were statistically significant.
The incidence of confirmed stroke increased at 0.35% per
annum prior to the legislation, after adjusting for changes in age,
sex, deprivation quintile and urban/rural residence, as well as
month. At the time of implementation there was a stepwise
absolute reduction of 6.65% (95% CI 2.95, 10.22, p,0.001)
(Table 2). The stepwise reduction reached statistical significance in
most sub-groups of the population (Table 2). None of the formal
tests for interactions between sub-groups were statistically signif-
icant.
Discussion
Following introduction of national smoke-free legislation, there
was a significant stepwise reduction in the incidence of cerebral
infarction relative to pre-legislation levels. By contrast, there was
no significant impact on intra-cerebral haemorrhage or unspec-
ified stroke. The reduction in cerebral infarction lasted for around
20 months before partially reverting to pre-legislation levels.
Following implementation of Scotland’s smoke-free legislation
in March 2006, there has been a very high level of compliance
[27], and a reduction in overall exposure to ETS in the general
population [28]. There was also a dramatic increase in smoking
quit attempts at the beginning of 2006, in anticipation of the
legislation, resulting in a significant fall in smoking prevalence
[29]. However, the beneficial effects on active smoking were not
maintained over time and, one year following the legislation, both
had reverted to levels not significantly different from the
underlying trends [29]. Whilst smoke free legislation may
encourage reduced consumption and increased quit attempts,
additional measures appear to be required if benefits are to be
maintained in the long-term. In the absence of information on the
smoking status of stroke patients, we can only speculate as to the
Figure 1. Time trends in stroke incidence (hospital admissions plus pre-hospital deaths). Footnote: graphs show lowess smoothed
incidence rates with a bandwidth of 0.1.
doi:10.1371/journal.pone.0062597.g001
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relative contribution of reduced active smoking and ETS to the fall
in cerebral infarctions at the time that smoke-free legislation was
implemented. After 20 months the reduction was partially reversed
but rates remained lower than predicted from the pre-legislation
trends. It is plausible that the partial reversal was due to the failure
to maintain a reduction in smoking prevalence.
In comparison with coronary heart disease, there have been
relatively few studies that have examined the impact of smoke-free
legislation on cerebrovascular disease. A study conducted in
Ontario, Canada, included stroke in the definition of cardiovas-
cular disease (along with acute myocardial infarction and angina)
and demonstrated a reduction following smoke-free legislation
[30]. To date, there have been three published studies that have
examined the impact of smoke-free legislation on stroke specifi-
cally, and none have reported the effect on sub-types of stroke.
Following state-wide legislation in Arizona, there were statistically
significant reductions in admissions for stroke in those counties
which did not have pre-existing local restrictions [31]. The
introduction of comprehensive legislation across New York State
produced no significant reduction in total admissions for all-cause
stroke over and above those following previous partial and local
restrictions [32]. A study conducted in New Zealand applied a
wide definition of stroke, including sub-dural and extra-dural
haemorrhage, as well as intra-cerebral haemorrhages and cerebral
infarction [33]. The investigators observed a significant fall in the
crude number of admissions in the year following legislation but
this did not remain statistically significant following adjustment for
potential confounders.
Table 1. Absolute changes in cerebral infarction incidence referent to pre-legislation slope.
Step change on 26 March 2006 Change in slope post 26 March 2006
n % (95% CI) P value % (95% CI) P value
Overall* 35,308 28.90 (212.77, 24.85) ,0.001 20.40 (21.86, 1.07) 0.590
Sex male 17,855 29.49 (215.40, 23.17) 0.004 0.06 (22.24, 2.43) 0.957
female 17,453 28.32 (212.99, 23.39) 0.001 20.85 (22.60, 0.93) 0.347
Age (years) ,60 5,652 29.26 (213.50, 24.82) ,0.001 0.19 (21.46, 1.87) 0.821
$60 29,656 27.42 (215.65, 1.61) 0.105 23.32 (25.45, 21.15) 0.003
Residence urban 25,233 28.68 (213.14, 23.99) ,0.001 20.59 (22.45, 1.31) 0.540
rural 10,075 29.39 (216.64, 21.50) 0.021 0.11 (21.97, 2.23) 0.919
Deprivation 1 affluent 5,171 210.88 (216.41, 24.98) ,0.001 22.01 (23.50, 20.54) 0.007
quintile 2 5,950 26.92 (210.33, 23.37) ,0.001 1.30 (0.15, 2.46) 0.027
3 6,790 213.29 (224.87, 0.07) 0.051 22.93 (26.05, 0.30) 0.181
4 8,212 21.73 (212.56, 10.43) 0.769 0.41 (21.91, 2.77) 0.733
5 deprived 9,185 210.31 (214.81, 25.59) ,0.001 2.42 (23.00, 8.13) 0.389
CI confidence interval.
*adjusted for sex, age, residence and deprivation quintile.
doi:10.1371/journal.pone.0062597.t001
Table 2. Absolute changes in confirmed stroke (cerebral infarction plus intracerebral haemorrhage) incidence referent to pre-
legislation slope.
Step change on 26 March 2006 Change in slope post 26 March 2006
n % (95% CI) P value % (95% CI) P value
Overall* 44,358 26.65 (210.22, 22.95) ,0.001 20.23 (21.49, 1.06) 0.728
Sex male 22,531 26.81 (211.82, 21.57) 0.012 20.12 (22.11, 1.92) 0.917
female 21,827 26.51 (211.31, 21.45) 0.012 20.32 (21.91, 1.29) 0.227
Age (years) ,60 7,536 27.13 (210.87, 23.24) ,0.001 0.36 (21.08, 1.81) 0.628
$60 36,822 24.76 (213.84, 5.29) 0.341 22.77 (24.73, 20.78) 0.007
Residence urban 31,653 26.12 (210.02, 22.06) 0.003 20.35 (21.99, 1.31) 0.673
rural 12,705 27.87 (214.99, 20.15) 0.046 0.14 (21.61, 1.92) 0.879
Deprivation 1 affluent 6,673 29.68 (214.61, 24.47) ,0.001 21.78 (23.81, 0.28) 0.090
quintile 2 7,523 24.63 (28.09, 21.03) 0.012 0.91 (0.02, 1.81) 0.045
3 8,608 211.82 (222.56, 0.41) 0.058 21.89 (25.00, 1.33) 0.246
4 10,252 22.20 (29.44, 5.62) 0.571 0.89 (21.71, 3.56) 0.506
5 deprived 11,302 22.47 (25.55, 0.71) 0.127 1.67 (22.44, 5.95) 0.432
CI confidence interval.
*adjusted for sex, age, residence and deprivation quintile.
doi:10.1371/journal.pone.0062597.t002
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In our study, we had access to high-quality data covering the
whole of Scotland. Therefore, the results cannot be attributed to
changes in hospital catchment areas or referral practice. We had
access to data on pre-hospital deaths, enabling us to examine
overall incidence rather than hospital admissions. Therefore, any
post-legislation changes cannot be attributed to a change in the
natural history or pre-hospital management of the condition.
Because we used record linkage to identify recurrent events in the
same individual we were able to exclude people with a past history
of stroke and only include incident events. This enabled us to
separate the association between legislation and incidence,
separately from any association with prognosis. In our study, we
were able to test for interactions with age, sex, deprivation and
urban/rural classification.
Our assumptions regarding the underlying trend were based on
data from six years prior to the legislation. Inclusion of more years
would have required use of ICD9 as well as ICD10 codes and
could have led to artefactual changes over time due to non-exact
mapping. Exploratory analyses (not shown) using data prior to
2000 showed evidence of a step changes in event rate at this time,
suggesting this to be the case. Because we used routine data
sources, we did not have access to information on smoking status
or to either self-reported or biochemical measures of level of ETS
exposure pre- and post-legislation. Therefore, we were unable to
determine whether the observed decline in cerebral infarction
occurred in non-smokers, smokers or both, and we cannot surmise
whether the association was mediated via a reduction in ETS
exposure or reduced consumption and increased quitting among
smokers. Scottish routine data undergo regular quality assurance
checks. However, as with any retrospective, secondary analyses
some data may be inaccurate or incomplete. From audit data, we
know that the proportion of patients admitted with stroke who
have undergone scans has increased over the study period,
resulting in an underlying decline in unspecified stroke and
increase in stroke classified as cerebral infarction [34]. However,
changes in scanning rates were minor in the two years before and
after the smoking legislation was introduced [34]. Over time there
have been many changes in stroke management, such as an
increase in the percentage of stroke patients admitted to hospital,
the introduction of multidisciplinary stroke teams and units,
educational campaigns to raise public awareness of stroke and the
need to phone for an ambulance, and use of thrombolysis, which
have impacted on community and in-hospital case-fatality.
Therefore, it was not possible to analyse fatal and non-fatal
strokes separately and determine the specific effect of the
legislation. There were no new, national tobacco control
initiatives, other than the smokefree legislation, introduced over
the period studied. However, in any natural history experiment it
is impossible to identify and exclude the effects of all the
interventions and influences that may have occurred.
Conclusions
Our study is the first to demonstrate a reduction in cerebral
infarction incidence following comprehensive, smoke-free legisla-
tion. Additional studies are required to corroborate our findings in
other countries, and to explore whether the reduction is due to
reduced risk in smokers or protection from ETS.
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Figure S1 Time trends in stroke incidence (hospital admissions
plus pre-hospital deaths) (equivalent to Figure 1 (confirmed stroke)
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line and 95% confidence intervals).
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